Article Summary
李甜 张亚楼 陈龙 秦纹 钟近洁.链脲佐菌素诱导C57小鼠1型糖尿病模型的研究[J].现代生物医学进展英文版,2014,14(26):5031-5033.
链脲佐菌素诱导C57小鼠1型糖尿病模型的研究
StudyofType1DiabetesModel InducedbyStreptozotocinintheC57Mouse
  
DOI:
中文关键词: 链脲佐菌素  1 型糖尿病  C57 小鼠
英文关键词: Streptozotocin  Type 1 diabetes  C57 mouse
基金项目:新疆医科大学校内支撑学科项目-人体解剖与组织胚胎学阶段性成果(XYDXK20780307); 国家自然科学基金项目(81160331,81360409);新疆医科大学科研创新基金(XJC201134,XJC201229)
Author NameAffiliation
LI Tian, ZHANG Ya-lou, CHEN Long, QIN Wen, ZHONG Jin-jie 新疆医科大学基础医学院组织胚胎学教研室新疆医科大学基础医学院机能实验中心 
Hits: 834
Download times: 4006
中文摘要:
      目的:通过小剂量多次腹腔注射链脲佐菌素(STZ)诱导建立与人类1 型糖尿病相似的C57 小鼠糖尿病模型,研究建模剂量 和成模率。方法:将32 只C57 小鼠随机分为正常对照组(A)和实验组(B)。实验组(B)可分为低、中、高剂量组(50 mg/kg、70 mg/kg、90 mg/kg)(n=8)。两组都喂普通饲料1 周后,B 组连续5 天腹腔注射不同剂量STZ,测定注射前、注射后1 周、2 周、3 周、4 周、5 周的空腹血糖和体重,观察小鼠饮食、饮水和排尿情况。STZ注射第3 周进行口服糖耐量实验(OGTT)。结果:给药前A、B 组 体重和血糖无显著差异,给药1 周后,B 组饮水量和进食量明显增加,体重减轻。C57小鼠用药2周后,中剂量组达到建模标准,成 模率75 %。各剂量组均出现了糖耐量异常。结论:诱导建立C57 小鼠1 型糖尿病模型方法是连续5 日腹腔注注射STZ,适宜剂量 为70 mg/kg。
英文摘要:
      Objective:To establish a C57 mouse model of type 1 diabetes by multiple intraperitoneal injection of low concentration STZ, and evaluate model effect and the success rate.Methods:32 C57 mice were randomly divided into normal control group (A) and experimental group (B). The experimental group (B) was divided into low, middle, high dose group (50 mg/kg, 70 mg/kg, 90 mg/kg) (n=8). The two groups were fed with normal diet for 1 week. Group B received different concentration of STZ for 5 consecutive days by intraperitoneal injection. Blood glucose were determined at pre-injection, 1 weeks after injection, 2 weeks, 3 weeks, 4 weeks, 5 weeks and body weight were also detected. At the same time animal's eating, drinking and voiding were recorded. 3 weeks after STZ injection. Oral glucose tolerance test (OGTT) was carried out at the same time.Results:Body weight and blood glucose group A and group B had no significant difference between group A and group B before drug administration. After treatment for 1 week, mice in group B had water intake and food intake increased, but weight lost. After 2 weeks medication, the C57 mice in middle dose group reached the standard of modeling, and the successful rate was 75%. Each dose group showed an impaired glucose tolerance.Conclusion:The establishment of type 1 diabetes model of C57 mice can be induced by STZ, with consecutive 5 days intraperitoneal injections, and suitable dose of 70 mg/kg.
View Full Text   View/Add Comment  Download reader
Close